🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 20 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 05/05/2016 | 108,88 | 109,43 | 106,98 | 107,77 | -0,40% | 2,25% | 541.200 |
| 04/05/2016 | 110,36 | 111,23 | 107,77 | 108,20 | -2,13% | 3,14% | 789.800 |
| 03/05/2016 | 109,68 | 113,00 | 108,51 | 110,55 | +0,33% | 4,09% | 759.600 |
| 02/05/2016 | 105,49 | 110,55 | 104,90 | 110,19 | +4,74% | 5,36% | 980.700 |
| 29/04/2016 | 103,74 | 107,59 | 103,74 | 105,20 | +0,34% | 3,71% | 1.019.700 |
| 28/04/2016 | 105,93 | 110,18 | 102,50 | 104,84 | -10,91% | 7,25% | 2.496.500 |
| 27/04/2016 | 117,11 | 119,19 | 116,20 | 117,68 | +0,20% | 2,55% | 793.900 |
| 26/04/2016 | 117,56 | 118,86 | 116,25 | 117,45 | +0,13% | 2,22% | 476.600 |
| 25/04/2016 | 118,41 | 119,36 | 116,21 | 117,30 | -1,93% | 2,66% | 502.800 |
| 22/04/2016 | 117,90 | 119,74 | 116,01 | 119,61 | +1,67% | 3,16% | 514.900 |
| 21/04/2016 | 115,02 | 117,79 | 114,31 | 117,65 | +2,08% | 3,03% | 657.700 |
| 20/04/2016 | 115,53 | 117,49 | 114,60 | 115,25 | +0,31% | 2,50% | 435.900 |
| 19/04/2016 | 116,24 | 116,51 | 113,21 | 114,89 | -1,01% | 2,84% | 480.000 |
| 18/04/2016 | 114,62 | 116,69 | 114,09 | 116,06 | +0,55% | 2,27% | 380.900 |
| 15/04/2016 | 114,32 | 116,27 | 113,80 | 115,43 | +0,65% | 2,16% | 548.800 |
| 14/04/2016 | 115,44 | 115,86 | 113,00 | 114,68 | -0,40% | 2,48% | 430.800 |
| 13/04/2016 | 111,39 | 116,08 | 111,11 | 115,14 | +4,53% | 4,46% | 873.100 |
| 12/04/2016 | 110,21 | 111,11 | 109,05 | 110,15 | +0,31% | 1,87% | 843.600 |
| 11/04/2016 | 112,40 | 112,40 | 108,31 | 109,81 | -2,77% | 3,64% | 773.000 |
| 08/04/2016 | 113,65 | 115,04 | 112,17 | 112,94 | -0,03% | 2,53% | 797.400 |
| 07/04/2016 | 115,55 | 115,85 | 112,00 | 112,97 | -2,22% | 3,33% | 979.500 |
| 06/04/2016 | 112,85 | 117,65 | 112,12 | 115,54 | +3,21% | 4,90% | 1.480.200 |
| 05/04/2016 | 112,98 | 114,37 | 111,49 | 111,95 | -1,38% | 2,55% | 1.052.500 |
| 04/04/2016 | 113,00 | 117,19 | 113,00 | 113,52 | +0,52% | 3,71% | 898.600 |
| 01/04/2016 | 111,20 | 113,49 | 109,85 | 112,93 | +1,35% | 3,27% | 1.012.800 |
| 31/03/2016 | 110,42 | 112,67 | 110,17 | 111,43 | +1,36% | 2,26% | 805.300 |
| 30/03/2016 | 110,96 | 113,93 | 108,66 | 109,94 | +0,29% | 4,75% | 901.100 |
| 29/03/2016 | 109,01 | 112,32 | 107,04 | 109,62 | +1,06% | 4,84% | 1.172.100 |
| 28/03/2016 | 109,67 | 112,85 | 108,40 | 108,47 | -0,37% | 4,06% | 1.228.900 |
| 24/03/2016 | 117,99 | 118,21 | 107,51 | 108,87 | -10,47% | 9,07% | 1.928.400 |